• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

FemTec Health Scoops up Nutrition Platform Nutrimedy

Share:

August 1, 2022

FemTec Health announced Monday it had acquired nutrition platform Nutrimedy, the latest in a spate of deals from the women’s health startup.

Nutrimedy allows users to take photos of their food to log their meals and offers nutrition recommendations. FemTec said it would integrate the tool into its Awesome Woman direct-to-consumer platform, which sends products like at-home tests and supplements to customers’ homes and provides telehealth visits.

The news comes about a week after FemTec announced it had purchased Ava AG, the maker of a wearable that aims to detect the user’s fertility window.

“For many health conditions, nutrition is a key, but often neglected, component,” Kimon Angelides, founder and CEO of FemTec, said in a statement. “Adding Nutrimedy’s robust, evidence-based clinical nutrition platform to the Awesome Woman program will be a game-changer for our subscribers. Whether it’s to optimize pregnancy planning, manage menopause symptoms, or for general wellness and prevention, research shows women seek personalized, science-backed nutritional support that’s easy to use and that they can trust.”

THE LARGER TREND

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Founded in 2020, FemTec officially launched in October 2021 with more than $38 million in investor dollars and another three acquisitions: beauty box company Birchbox, cosmetics company Mira Beauty, and social marketing platform Liquid Grids. It announced its direct-to-consumer program earlier this year.

Digital women’s health startups have steadily grown in funding over the past few years, though experts argue there’s more opportunity in the space. Reproductive and maternal health was the fifth-highest funded clinical area in Rock Health’s investment report for the first half of 2022, bringing in $0.6 billion so far.

Meanwhile, there are a number of women-focused digital health companies. Maternal care startups Cayaba Care and Mahmee raised Series A rounds this year. Ruth Health, which provides virtual pelvic-floor physical therapy, C-section recovery, and lactation consulting, announced $2.4 million in seed funding in April. Evernow recently raised $28.5 million for its menopause-focused service.

Other women-focused digital health companies include Alpha Medical, Tia, and Maven Clinic.

ON THE RECORD

“Nutrimedy was started with the mission to improve access to nutrition in healthcare and make it significantly more personalized and actionable in our hectic daily routines. Within the field of nutrition, conflicting and confusing misinformation is pervasive and prevents most people from making the best decision for their individual health,” Nutrimedy CEO and cofounder Karolina Starczak said in a statement. “This is especially true in women’s health, where quick fixes and false promises prevent women from accessing viable solutions to their medical and nutritional needs.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Vizgen Launches with $14M Series a Financing Led By ARCH Venture Partners and Northpond VenturesVizgen Launches with $14M Series a Financing Led By ARCH Venture Partners and Northpond Ventures
  • AbCellera Acquires OrthoMab Bispecific Platform to Propel the Development of Antibody Therapies for Pharma and Biotech PartnersAbCellera Acquires OrthoMab Bispecific Platform to Propel the Development of Antibody Therapies for Pharma and Biotech Partners
  • Biodesix Partners with Streck to Support in Vitro Diagnostic (IVD) StrategyBiodesix Partners with Streck to Support in Vitro Diagnostic (IVD) Strategy
  • Catalyst Biosciences Sells Complement Portfolio for $60 MillionCatalyst Biosciences Sells Complement Portfolio for $60 Million
  • TOP 25 Artificial Intelligence Companies 2018TOP 25 Artificial Intelligence Companies 2018
  • VC Firm General Catalyst Partners Lands First NHS Trust Partnership in UKVC Firm General Catalyst Partners Lands First NHS Trust Partnership in UK
  • Central Logic Integrates Offering and Rebrands to ABOUTCentral Logic Integrates Offering and Rebrands to ABOUT
  • Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital PathologyProscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications